X-32342105-G-C

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_004006.3(DMD):​c.5917C>G​(p.Gln1973Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000914 in 1,094,574 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q1973H) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 23)
Exomes 𝑓: 9.1e-7 ( 0 hom. 0 hem. )

Consequence

DMD
NM_004006.3 missense

Scores

2
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.73

Publications

2 publications found
Variant links:
Genes affected
DMD (HGNC:2928): (dystrophin) This gene spans a genomic range of greater than 2 Mb and encodes a large protein containing an N-terminal actin-binding domain and multiple spectrin repeats. The encoded protein forms a component of the dystrophin-glycoprotein complex (DGC), which bridges the inner cytoskeleton and the extracellular matrix. Deletions, duplications, and point mutations at this gene locus may cause Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), or cardiomyopathy. Alternative promoter usage and alternative splicing result in numerous distinct transcript variants and protein isoforms for this gene. [provided by RefSeq, Dec 2016]
DMD Gene-Disease associations (from GenCC):
  • Becker muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • dilated cardiomyopathy 3B
    Inheritance: XL Classification: DEFINITIVE Submitted by: Ambry Genetics
  • Duchenne and Becker muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE Submitted by: Myriad Women’s Health
  • Duchenne muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • progressive muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.12822792).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004006.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DMD
NM_004006.3
MANE Select
c.5917C>Gp.Gln1973Glu
missense
Exon 41 of 79NP_003997.2
DMD
NM_004009.3
c.5905C>Gp.Gln1969Glu
missense
Exon 41 of 79NP_004000.1
DMD
NM_000109.4
c.5893C>Gp.Gln1965Glu
missense
Exon 41 of 79NP_000100.3

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DMD
ENST00000357033.9
TSL:1 MANE Select
c.5917C>Gp.Gln1973Glu
missense
Exon 41 of 79ENSP00000354923.3
DMD
ENST00000378677.6
TSL:5
c.5905C>Gp.Gln1969Glu
missense
Exon 41 of 79ENSP00000367948.2
DMD
ENST00000619831.5
TSL:5
c.1885C>Gp.Gln629Glu
missense
Exon 13 of 51ENSP00000479270.2

Frequencies

GnomAD3 genomes
Cov.:
23
GnomAD4 exome
AF:
9.14e-7
AC:
1
AN:
1094574
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
360430
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26352
American (AMR)
AF:
0.00
AC:
0
AN:
35088
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19323
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30052
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53880
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40441
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4116
European-Non Finnish (NFE)
AF:
0.00000119
AC:
1
AN:
839383
Other (OTH)
AF:
0.00
AC:
0
AN:
45939
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
23
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Duchenne muscular dystrophy Uncertain:1
Jun 07, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with DMD-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces glutamine with glutamic acid at codon 1973 of the DMD protein (p.Gln1973Glu). The glutamine residue is highly conserved and there is a small physicochemical difference between glutamine and glutamic acid.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.089
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.61
CADD
Benign
19
DANN
Benign
0.92
DEOGEN2
Benign
0.21
T
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.74
T
M_CAP
Benign
0.032
D
MetaRNN
Benign
0.13
T
MetaSVM
Benign
-1.1
T
PhyloP100
2.7
PrimateAI
Uncertain
0.49
T
PROVEAN
Benign
-0.17
N
REVEL
Benign
0.082
Sift
Benign
0.059
T
Sift4G
Benign
0.20
T
Polyphen
0.0020
B
Vest4
0.22
MutPred
0.63
Loss of MoRF binding (P = 0.0421)
MVP
0.51
MPC
0.018
ClinPred
0.11
T
GERP RS
4.9
gMVP
0.18
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs863225005; hg19: chrX-32360222; API